Skip to main content

Table 1 Basic clinical data of analyzed cases

From: Pyramidal system involvement in progressive supranuclear palsy – a clinicopathological correlation

 

n

Gender (M/F)

Age at onset

Duration from disease onset (years)

PSP-RS

10

7/3

62 (51–70)

5.8 (3–9)

PSP-nonRS

8

6/2

70 (60–83)

6 (2–12)

 

PSP–CBS

3

2/1

66 (60–76)

6 (2–12)

PSP-P

3

2/1

68 (66–70)

6.7 (5–7)

PSP-PGF

1

1/0

83

4

PSP-SL

1

1/0

77

6

Total

18

13/5

69 (58–83)

5.9 (2–12)

  1. Values (when applicable) are shown as the mean (min–max); PSP subtypes according to the 2017 MDS PSP Criteria (Höglinger et al.)